Péptidos

A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2U1 antibody, catalog no. 70R-10392

A synthetic peptide for use as a blocking control in assays to test for specificity of TRIB3 antibody, catalog no. 70R-3572

A synthetic peptide for use as a blocking control in assays to test for specificity of MGC33407 antibody, catalog no. 70R-4401

A synthetic peptide for use as a blocking control in assays to test for specificity of SLCO1C1 antibody, catalog no. 70R-6553

A synthetic peptide for use as a blocking control in assays to test for specificity of PHACTR1 antibody, catalog no. 70R-4246

A synthetic peptide for use as a blocking control in assays to test for specificity of Ppp2r5e antibody, catalog no. 70R-9426

A synthetic peptide for use as a blocking control in assays to test for specificity of TRPM3 antibody, catalog no. 70R-1517

A synthetic peptide for use as a blocking control in assays to test for specificity of SIN3B antibody, catalog no. 20R-1129

A synthetic peptide for use as a blocking control in assays to test for specificity of BAG5 antibody, catalog no. 70R-10407

A synthetic peptide for use as a blocking control in assays to test for specificity of XRCC5 antibody, catalog no. 70R-1235

A synthetic peptide for use as a blocking control in assays to test for specificity of FJX1 antibody, catalog no. 70R-6368

A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA1189 antibody, catalog no. 70R-4446

CGRP (Human, 8-37) is a peptide derived from the calcitonin gene-related peptide (CGRP) that is found in the nervous system and other tissues in humans. It is a truncated form of the full-length CGRP peptide, consisting of the last 30 amino acids of the CGRP sequence (amino acids 8-37).
CGRP is a potent vasodilator and plays a key role in regulating blood flow and blood pressure. It is also involved in pain perception, inflammation, and neurogenic inflammation. CGRP (Human, 8-37) is an antagonist of CGRP, meaning that it binds to the CGRP receptor without activating it, thereby blocking the effects of CGRP.
CGRP (Human, 8-37) has been used as a research tool to study the physiological and pathological roles of CGRP in various tissues and diseases, such as migraine headaches, cardiovascular diseases, and inflammatory disorders. It has also been investigated as a potential therapeutic agent for these conditions, as well as for the treatment of pain and other neurological disorders.
This product is available as a 0.5mg vial.

Vasotocin is a peptide hormone that is found in the hypothalamus. It is an activator of the vasopressin receptor and has been shown to activate ion channels and inhibit the release of neurotransmitters. Vasotocin also binds to a specific receptor on the surface of cells, which may be involved in cell biology and may have applications in pharmacology and antibody research. Vasotocin is purified from pig pituitary glands.

A synthetic peptide for use as a blocking control in assays to test for specificity of GSTA3 antibody, catalog no. 70R-2939

Antipain is a proteolytic enzyme that hydrolyzes peptide bonds in proteins. It is a member of the papain family of proteases and has been shown to activate peptides and inhibit ion channels, both of which are important for cell biology research. Antipain, an inhibitor of protein synthesis, is also used as a research tool in cell biology and biochemistry.

A synthetic peptide for use as a blocking control in assays to test for specificity of TXNDC13 antibody, catalog no. 70R-7432

A synthetic peptide for use as a blocking control in assays to test for specificity of TSKS antibody, catalog no. 70R-2687

A synthetic peptide for use as a blocking control in assays to test for specificity of JOSD2 antibody, catalog no. 70R-4142

A synthetic peptide for use as a blocking control in assays to test for specificity of NUDT9 antibody, catalog no. 70R-5105

Azido-dPEG®3-Amine is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Azido-dPEG®3-Amine is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of C18orf10 antibody, catalog no. 70R-3403

A synthetic peptide for use as a blocking control in assays to test for specificity of Scfd2 antibody, catalog no. 70R-9215

t-boc-N-Amido-dPEG®24-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. t-boc-N-Amido-dPEG®24-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of DAZAP1 antibody, catalog no. 70R-4724

A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA0317 antibody, catalog no. 70R-6288

A synthetic peptide for use as a blocking control in assays to test for specificity of RGD1307041 antibody, catalog no. 70R-9487

A synthetic peptide for use as a blocking control in assays to test for specificity of ENPP2 antibody, catalog no. 70R-6767

MAL-dPEG®4-t-boc-Hydrazide is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. MAL-dPEG®4-t-boc-Hydrazide is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of NR2F2 antibody, catalog no. 20R-1220

A synthetic peptide for use as a blocking control in assays to test for specificity of CDCA5 antibody, catalog no. 70R-2883

A synthetic peptide for use as a blocking control in assays to test for specificity of PAPOLG antibody, catalog no. 70R-4710

A synthetic peptide for use as a blocking control in assays to test for specificity of BBS5 antibody, catalog no. 70R-9214

A synthetic voltage-dependent K+ channel blocker derived from bee venom. This product is sourced from the Honeybee, Apis mellifera and has disulfide bonds between Cys3-Cys15 and Cys5-Cys19.
Available as a 0.5mg vial.

Dnp-Pro-Gln-Gly is a synthetic peptide that can be used as an artificial substrate in protease assays. It is activated by the addition of trypsin and catalyzes hydrolysis of peptide bonds at the C-terminus of the proline residue. The chromatographic profile of Dnp-Pro-Gln-Gly on a Zorbax 300SBX column shows two peaks, with retention times of 8.2 minutes and 9.4 minutes. In tissue culture experiments, Dnp-Pro-Gln-Gly was found to enhance the activity of matrix metalloproteinases and collagenase. The optimum pH for Dnp-Pro-Gln-Gly is 5.5, which is near the pH optimum for most mammalian tissues and organs.

A synthetic peptide for use as a blocking control in assays to test for specificity of TRPC6 antibody, catalog no. 70R-5132

APYTFGQGTK peptide is a sequence from light chain of Adalimumab monoclonal antibody. Due to its universal location in Adalimumab antibody, APYTFGQGTK is used as a specific signature peptide for the quantitation of Adalimumab. Indeed, proteomic studies allows quantification of proteins in blood samples.
What is Adalimumab?
Adalimumab corresponds to a therapeutic monoclonal antibody. It is a subcutaneously administered biological disease modifier for the treatment of rheumatoid arthritis and other chronic debilitating diseases mediated by tumor necrosis factor. This drug is frequently known as Humira.

A synthetic peptide for use as a blocking control in assays to test for specificity of TTC16 antibody, catalog no. 70R-2970

A synthetic peptide for use as a blocking control in assays to test for specificity of DHRSX antibody, catalog no. 70R-7875

A synthetic peptide for use as a blocking control in assays to test for specificity of C19orf28 antibody, catalog no. 70R-6748

A synthetic peptide for use as a blocking control in assays to test for specificity of ATG3 antibody, catalog no. 70R-9260

Z-Ala-Ala-Asn-AMC is a peptide that can be used as an inhibitor, activator, or ligand for protein interactions. It is also a research tool and antibody production reagent. This compound has high purity and is suitable for both in vitro and in vivo research.

A synthetic peptide for use as a blocking control in assays to test for specificity of RPS9 antibody, catalog no. 70R-10369

Lipoamido-dPEG®4-Acid is a PEG molecule conjugated with a lipid moiety. Lipoamido-dPEG®4-Acid, conjugated to this lipid constituent, is very important especially in drug delivery and vaccine development as it helps improve the stability and circulation time of lipid nanoparticles (LNPs) and liposomes.

A synthetic peptide for use as a blocking control in assays to test for specificity of SSX8 antibody, catalog no. 70R-9114

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNA10 antibody, catalog no. 70R-1497

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF768 antibody, catalog no. 70R-9586

D-Ala2,Met5]-Enkephalinamide is a potent endogenous opioid peptide that binds to opioid receptors and has been shown to have both antinociceptive and depressant effects. It has been shown to be effective in a model system of pain, acting on the descending antinociceptive pathway from the rostral ventromedial medulla (RVM) to the spinal cord. D-Ala2,Met5]-Enkephalinamide has also been observed to inhibit locomotor activity in CD1 mice at sub-effective doses. D-Ala2,Met5]-Enkephalinamide has been shown to act through activation of both G protein-coupled mu opioids receptors and G protein-coupled delta opioid receptors.

A synthetic peptide for use as a blocking control in assays to test for specificity of ADAMTS18 antibody, catalog no. 70R-4602

A synthetic peptide for use as a blocking control in assays to test for specificity of CTSL2 antibody, catalog no. 70R-10281

A synthetic peptide for use as a blocking control in assays to test for specificity of LRRC4C antibody, catalog no. 70R-6577

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF485 antibody, catalog no. 70R-8116

A synthetic peptide for use as a blocking control in assays to test for specificity of MITD1 antibody, catalog no. 70R-4506

A synthetic peptide for use as a blocking control in assays to test for specificity of Cdx1 antibody, catalog no. 70R-8239

A synthetic peptide for use as a blocking control in assays to test for specificity of ANAPC10 antibody, catalog no. 70R-5616

A synthetic peptide for use as a blocking control in assays to test for specificity of Lpcat2 antibody, catalog no. 70R-8680

Fmoc-N-Amido-dPEG®6-Acid is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Fmoc-N-Amido-dPEG®6-Acid is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of RBM14 antibody, catalog no. 70R-5676

SARS Coronavirus is an enveloped virus containing 3 outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein takes part in the virus infection cycle and is the primary target of neutralizing antibodies. SARS Spike produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 219 amino acids (306-515 aa) and having a molecular mass of 24.7kDa.SARS Spike is fused to a 6 amino acid His tag at C-terminus and purified by proprietary chromatographic techniques. The formulation of the SARS Spike (306-515) solution (0.5mg/ml) contains Phosphate-Buffered Saline (pH 7.4) and 10% Glycerol. Biological Activity: Measured by its binding ability in a functional ELISA with Human ACE-2 (CAT# enz-1159).
One-Letter Formula: ADPRVVPSGD VVRFPNITNL CPFGEVFNAT KFPSVYAWER KKISNCVADY SVLYNSTFFS TFKCYGVSAT KLNDLCFSNV YADSFVVKGD DVRQIAPGQT GVIADYNYKL PDDFMGCVLA WNTRNIDATS TGNYNYKYRY LRHGKLRPFE RDISNVPFSP DGKPCTPPAL NCYWPLNDYG FYTTTGIGYQ PYRVVVLSFE LLNAPATVCG PKLHHHHHH

A synthetic peptide for use as a blocking control in assays to test for specificity of TRAM2 antibody, catalog no. 70R-6865

A synthetic peptide for use as a blocking control in assays to test for specificity of PDS5A antibody, catalog no. 70R-3908

A synthetic peptide for use as a blocking control in assays to test for specificity of DENND1B antibody, catalog no. 70R-7093

A synthetic peptide for use as a blocking control in assays to test for specificity of Rod1 antibody, catalog no. 70R-8483

4-Formyl-Benzamido-dPEG®24-TFP Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. 4-Formyl-Benzamido-dPEG®24-TFP Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.

A synthetic peptide for use as a blocking control in assays to test for specificity of CYP8B1 antibody, catalog no. 70R-9994

A synthetic peptide for use as a blocking control in assays to test for specificity of RGD1563533 antibody, catalog no. 70R-8334

A synthetic peptide for use as a blocking control in assays to test for specificity of NHLRC2 antibody, catalog no. 70R-3406

A synthetic peptide for use as a blocking control in assays to test for specificity of ITPK1 antibody, catalog no. 70R-3684

A synthetic peptide for use as a blocking control in assays to test for specificity of SP140 antibody, catalog no. 20R-1079

A synthetic peptide for use as a blocking control in assays to test for specificity of UCHL5 antibody, catalog no. 70R-3208

A synthetic peptide for use as a blocking control in assays to test for specificity of MMP19 antibody, catalog no. 70R-1300

A synthetic peptide for use as a blocking control in assays to test for specificity of AGA antibody, catalog no. 70R-10228

A synthetic peptide for use as a blocking control in assays to test for specificity of IGF2BP1 antibody, catalog no. 70R-4908

Bis-dPEG®5-Acid is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®5-Acid is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.

Sar1, Ile4,8]-Angiotensin II is a peptide that belongs to the class of angiotensins. It has been shown to activate angiotensin receptors and is used as a research tool in pharmacology and cell biology. Sar1, Ile4,8]-Angiotensin II interacts with ligands such as heparin-binding EGF-like growth factor (HB-EGF) and angiopoietin 1 (ANGPT1). The antibody against Sar1, Ile4,8]-Angiotensin II blocks the receptor binding activity of this peptide. Sar1, Ile4,8]-Angiotensin II has been shown to be an inhibitor of ion channels such as inward rectifier potassium channels.

A synthetic peptide for use as a blocking control in assays to test for specificity of BCKDHA antibody, catalog no. 70R-5330

A synthetic peptide for use as a blocking control in assays to test for specificity of CBFA2T2H antibody, catalog no. 70R-8208

A synthetic peptide for use as a blocking control in assays to test for specificity of SNRPN antibody, catalog no. 70R-8478

A synthetic peptide for use as a blocking control in assays to test for specificity of RPA1 antibody, catalog no. 70R-5545

A synthetic peptide for use as a blocking control in assays to test for specificity of TMCO1 antibody, catalog no. 70R-6893

A synthetic peptide for use as a blocking control in assays to test for specificity of CRYGC antibody, catalog no. 70R-2030

A synthetic peptide for use as a blocking control in assays to test for specificity of AKR1B10 antibody, catalog no. 70R-1278

A synthetic peptide for use as a blocking control in assays to test for specificity of SPAG4L antibody, catalog no. 70R-4453

A synthetic peptide for use as a blocking control in assays to test for specificity of CENPH antibody, catalog no. 70R-5517

A synthetic peptide for use as a blocking control in assays to test for specificity of DDX50 antibody, catalog no. 70R-1367

A synthetic peptide for use as a blocking control in assays to test for specificity of LFNG antibody, catalog no. 70R-6332

A synthetic peptide for use as a blocking control in assays to test for specificity of CTRL antibody, catalog no. 70R-5436

A synthetic peptide for use as a blocking control in assays to test for specificity of DDX31 antibody, catalog no. 70R-1386

Anti-Luminal Cholecystokinin Releasing Factor (LCRF) is a protein that binds to the LCRF receptor. It is a research tool that can be used in immunohistochemistry and Western blotting. This antibody can be used as a marker of LCRF, which is involved in regulating intestinal motility and gastric emptying.

A synthetic peptide for use as a blocking control in assays to test for specificity of MNS1 antibody, catalog no. 70R-9486

A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGEF19 antibody, catalog no. 70R-4538

A synthetic peptide for use as a blocking control in assays to test for specificity of PLD2 antibody, catalog no. 70R-8244

A synthetic peptide for use as a blocking control in assays to test for specificity of TSPAN15 antibody, catalog no. 70R-7190

A synthetic peptide for use as a blocking control in assays to test for specificity of PRKACB antibody, catalog no. 70R-9393

A synthetic peptide for use as a blocking control in assays to test for specificity of FZD7 antibody, catalog no. 70R-7269

A synthetic peptide for use as a blocking control in assays to test for specificity of C19orf21 antibody, catalog no. 70R-4193

A synthetic peptide for use as a blocking control in assays to test for specificity of Ier3ip1 antibody, catalog no. 70R-8674